U.S. Software Stock News

What recent performance suggests about Utz Brands (UTZ) Utz Brands (UTZ) has been on investors’ radars after a mixed run, with the stock roughly flat over the past month but showing a return decline over the past 3 months and past year. At a last close of US$7.72 and a market cap of about US$1.19b, the company sits in an interesting spot for snack sector investors who are weighing current pricing against its recent performance profile. See our latest analysis for Utz Brands. For context, Utz...

National Vision Holdings is set to report its Q1 2026 results on May 13, with Wall Street expecting earnings per share of US$0.43 and revenue growth alongside higher comparable store sales. Analysts are watching for signs of improved operating leverage and margin performance, as well as how management characterizes consumer demand and competition across its optical retail formats. With expectations for higher earnings and mid-single-digit revenue growth, we'll examine how this upcoming...

Key earnings takeaways for Surgery Partners (SGRY) Surgery Partners (SGRY) kicked off 2026 with first quarter results that paired revenue growth with a narrower loss, while management reaffirmed full year guidance and highlighted ongoing cost discipline and portfolio work. The company reported Q1 revenue of US$810.9 million, basic and diluted loss per share from continuing operations of US$0.28, and an overall net loss of US$35.9 million. Management reiterated full year 2026 revenue guidance...

National Storage Affiliates Trust recently reported past first quarter 2026 results, with revenue of US$185.4 million and net income rising to US$17.78 million, lifting diluted earnings per share from continuing operations to US$0.16. Alongside this, an updated filing showed Prudential Financial and its subsidiaries collectively hold about 1.8% of the company’s common stock, highlighting continuing institutional interest in the self-storage REIT. With higher earnings per share despite...

If you are wondering whether Harmonic at US$12.28 is offering fair value or an opportunity, you will want to look past the headline share price and into what the valuation signals are really saying. The stock has recently shown sharp moves, with returns of 7.4% over the past week, 30.9% over the last 30 days, 22.6% year to date and 35.2% over the past year, set against a 22.8% decline over 3 years and a 78.2% gain over 5 years. Recent coverage around Harmonic has focused on its role as a...

Stock performance context for indie Semiconductor indie Semiconductor (INDI) has drawn fresh attention after a strong month, with the stock returning about 55% over that period, while the past 3 months show a gain of roughly 14%. For readers watching shorter term swings, the move comes after a modest 1 day decline of about 2% and a flat week, which contrasts with a year total return of around 93% and a 3 year loss near 44%. See our latest analysis for indie Semiconductor. At a share price of...

Wondering whether Silicon Motion Technology's current share price matches its underlying worth, or if expectations have simply raced ahead of fundamentals. The stock last closed at US$242.71, with returns of 10.9% over 7 days, 107.4% over 30 days, 158.9% year to date and 368.2% over the past year. This puts valuation questions front and center. Recent coverage has focused on the stock's sharp gains and what they might signal about investor confidence and changing risk perception. This kind...

Wilson Bank Holding (WBHC) opened 2026 with Q1 revenue of US$60.8 million and basic EPS of US$1.82, while trailing 12 month revenue stood at US$229.8 million and EPS was US$6.73, supported by earnings growth of 35.6% over the past year. Over recent periods the company has seen revenue move from US$181.7 million and EPS of US$4.79 on a trailing 12 month basis at Q4 2024 to US$219.9 million and EPS of US$6.28 by Q4 2025. This sets up the latest quarter against a track record of expanding profit...

Hill York Service, an EMCOR Group subsidiary, has been selected as the official HVAC partner for Inter Miami CF's new Nu Stadium. The agreement covers HVAC systems for the new venue and aligns EMCOR with a high profile sports facility project. This development adds a fresh angle to the EMCOR story beyond recent attention on quarterly results and guidance. For investors tracking EMCOR Group (NYSE:EME), the Hill York Service partnership with Inter Miami CF comes on top of a stock that has...

Backblaze (BLZE) drew fresh attention after first quarter 2026 results, with revenue of US$38.67 million and a net loss of US$6.15 million, alongside higher full year revenue guidance. See our latest analysis for Backblaze. The beat and raise has been met with sharp buying interest, with Backblaze’s share price at US$7.50 and a 30 day share price return of 107.18%, while the 1 year total shareholder return sits at 42.86%. This suggests strong recent momentum on expectations for AI related...

Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III data from LUCIDITY are expected next quarter. The company has also started a U.S. expanded access program so certain PBH patients can receive avexitide before any potential approval. Amylyx Pharmaceuticals focuses on therapies for serious neurological and metabolic conditions, with avexitide as its lead candidate for PBH. PBH can...

TSS, Inc. reported past first-quarter 2026 results with revenue of US$55.35 million and net income of US$2.28 million, down from US$98.96 million and US$2.98 million a year earlier, alongside lower earnings per share. Despite lower headline revenue, management highlighted strong AI-driven systems integration activity, maintained its full-year adjusted EBITDA outlook, and reinforced its AI infrastructure focus with senior hires in strategy and technology. We’ll now examine how this AI-fueled...

Trupanion (TRUP) has moved into focus after reporting first quarter 2026 results, showing net income of US$4.88 million, compared with a net loss of US$1.48 million in the same period a year earlier. See our latest analysis for Trupanion. Recent trading reflects a mixed picture, with a 2.69% 1 day share price return and 6.67% 7 day share price return contrasting with a 31.21% year to date share price decline and a 41.92% 1 year total shareholder return decline. This suggests recent momentum...

For investors wondering whether Fluor stock still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you are getting. Fluor recently closed at US$51.08, with returns of 7.0% over 30 days, 22.5% year to date and 43.4% over 1 year. This puts its longer term 3 year and 5 year returns at 93.0% and 169.8% respectively. Recent coverage has highlighted Fluor's role as a large engineering and...

Wondering if Unity Software at around US$26.73 is offering fair value or if the stock price is out of sync with the business? This article walks through what the numbers are saying so you can judge that for yourself. The stock has returned 1.2% over the past week and 21.4% over the last 30 days, while year to date it shows a 39.6% decline and a 29.4% return over the past year, highlighting that sentiment around risk and potential has shifted more than once. Recent headlines have focused on...

If you are wondering whether BellRing Brands' current share price offers value or just more volatility, it helps to start with what the recent returns are actually telling you. The stock last closed at US$10.46, with returns of a 41.2% decline over 7 days, a 33.2% decline over 30 days, a 59.9% decline year to date and an 83.1% decline over the past year. This clearly changes how many investors think about its potential and its risks. Recent coverage has focused on how the company fits into...

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...

Why Patria Investments (PAX) is on investors’ radar today Patria Investments (PAX) has drawn attention after recent trading left the stock around $12.04, with returns showing mixed signals over the past week, month and past 3 months. See our latest analysis for Patria Investments. The recent 6.8% one day share price decline and 24.4% year to date share price loss contrast with a 9.8% one year total shareholder return. This suggests that recent momentum has faded even as income and past...

Korn Ferry (NYSE:KFY) has been named America’s Best Executive Recruiter by Forbes Magazine for the ninth time in ten years. The recognition highlights Korn Ferry’s position among the top professional search firms in the United States. Korn Ferry’s latest recognition comes as the stock trades at $67.14, with a 3.8% return over the past year and a 51.2% return over three years. The company’s track record in executive recruitment, reflected in this recurring award, helps frame NYSE:KFY as a...

Kennametal Inc. recently reported its fiscal 2026 third-quarter results, with sales rising to US$592.59 million and net income reaching US$58.23 million, while also raising full-year sales guidance to a range of US$2.33 billion to US$2.35 billion. Alongside the stronger earnings and upgraded outlook, the company affirmed a quarterly dividend of US$0.20 per share, highlighting management’s confidence in cash generation and balance sheet flexibility. We’ll now examine how Kennametal’s raised...

Celcuity's lead drug candidate, gedatolisib, produced positive Phase 3 results in the VIKTORIA-1 trial for PIK3CA-mutant HR+/HER2- metastatic breast cancer. The trial met its primary endpoint and showed a significant improvement in progression-free survival. Celcuity plans to submit a supplemental NDA to the FDA, with full data scheduled for presentation at ASCO 2026. The program follows an existing Priority Review for gedatolisib in the wild-type population, with an FDA decision...

Wondering whether Mattel at around US$15.00 is starting to look like value, or if the stock still has more to prove before it deserves a spot in your portfolio. The share price has moved about 0.5% lower over the last 7 days, after a 4.0% gain over the last 30 days, and is currently sitting on a 25.1% decline year to date and a 13.1% decline over the last year. These moves come as investors weigh up the latest developments around the business and its position in the wider toy and...